Aridis pharmaceuticals announces q1 results

Aridis pharmaceuticals announces first quarter 2020 results.q1 loss per share $0.73.q1 earnings per share estimate $-0.67 -- refinitiv ibes data.total cash and cash equivalents as of march 31, 2020 was $16.3 million..grant revenue decreased from about $1.0 million for quarter ended march 31, 2019 to zero for quarter ended march 31.

ARDS Ratings Summary

ARDS Quant Ranking